The France Anesthesia Devices Market size is estimated at USD 0.79 billion in 2024, and is expected to reach USD 1.13 billion by 2029, growing at a CAGR of 7.20% during the forecast period (2024-2029).
COVID-19 pandemic had a substantial impact on patients with any diseases and the healthcare system. The strict lockdowns and government regulations intended to slow down the spread of COVID-19 hampered the anesthesia device market. For instance, an article published in PubMed titled 'Routine surgeries during the COVID-19 pandemic: A French nationwide cohort study' in May 2022 stated that there was a marked decrease in four routine surgeries compared to expectations through to at least the first half of 2021, despite the gradual national rollout of the vaccine. Revisions and non-elective interventions also decreased but to a lesser magnitude. The activity was lower than expected in 2020, cataract surgery: 21.9% ; hip arthroplasty: 13.4%; knee arthroplasty: 24.6% ; coronary angioplasty: 11.2% without any catch-up in the first half of 2021. The effect of COVID-19 on surgical procedures is far and wide, going from the labor force and staffing issues, procedural prioritization, and viral transmission hazard intraoperatively.
The surge in the coronavirus virus cases worldwide resulted in the utilization of all available intensive care unit (ICU) ventilators and anesthesia machines for longer-term ventilation of COVID-19 or other critically ill patients. Thus, higher demand of anesthesia drugs and devices during COVID-19 had a positive impact on the growth of anesthesia devices market.
The increasing number of surgical procedures, rise in geriatric population prone to illness, and technological advancements in anesthesia devices are some of the major factors that are expected to drive market growth. For instance, one of the major health issues in France is the growing burden of cancer. According to the data of Global Cancer Observatory 2020, cancer rate for men and women combined was at 422 people per 100,000 in France.
Also, according to the world atlas in 2021, population aged 65 years and above for France was 21.1 %. Population aged 65 years and above of France increased from 13.2 % in 1972 to 21.1 % in 2021 growing at an average annual rate of 0.97%. Therefore, with the aforementioned factors, the demand for anesthesia devices is expected to flourish during the forecast period.
Furthermore, the country has the presence of advanced products that are expected to accelerate market growth. For instance, in December 2021, MDoloris Medical Systems and Mindray, a global leader in developing and providing advanced medical devices and solutions, announced the CE Mark and upcoming launch of the Mdoloris ANI-MR module. Also, in October 2020, Mindray hosted a virtual launch event to introduce it's brand new A9 and A8 anesthesia systems, which are now available in Europe and other selected regions. The machines integrate automatic controlled anesthesia (ACA) and high flow nasal cannula oxygen (HFNC), which extend safe apnoeic time from 8 to up to 30 minutes to help clinicians intubate more easily. Hence all these factors are expected to propel the market growth in this segment.
This product will be delivered within 2 business days.
COVID-19 pandemic had a substantial impact on patients with any diseases and the healthcare system. The strict lockdowns and government regulations intended to slow down the spread of COVID-19 hampered the anesthesia device market. For instance, an article published in PubMed titled 'Routine surgeries during the COVID-19 pandemic: A French nationwide cohort study' in May 2022 stated that there was a marked decrease in four routine surgeries compared to expectations through to at least the first half of 2021, despite the gradual national rollout of the vaccine. Revisions and non-elective interventions also decreased but to a lesser magnitude. The activity was lower than expected in 2020, cataract surgery: 21.9% ; hip arthroplasty: 13.4%; knee arthroplasty: 24.6% ; coronary angioplasty: 11.2% without any catch-up in the first half of 2021. The effect of COVID-19 on surgical procedures is far and wide, going from the labor force and staffing issues, procedural prioritization, and viral transmission hazard intraoperatively.
The surge in the coronavirus virus cases worldwide resulted in the utilization of all available intensive care unit (ICU) ventilators and anesthesia machines for longer-term ventilation of COVID-19 or other critically ill patients. Thus, higher demand of anesthesia drugs and devices during COVID-19 had a positive impact on the growth of anesthesia devices market.
The increasing number of surgical procedures, rise in geriatric population prone to illness, and technological advancements in anesthesia devices are some of the major factors that are expected to drive market growth. For instance, one of the major health issues in France is the growing burden of cancer. According to the data of Global Cancer Observatory 2020, cancer rate for men and women combined was at 422 people per 100,000 in France.
Also, according to the world atlas in 2021, population aged 65 years and above for France was 21.1 %. Population aged 65 years and above of France increased from 13.2 % in 1972 to 21.1 % in 2021 growing at an average annual rate of 0.97%. Therefore, with the aforementioned factors, the demand for anesthesia devices is expected to flourish during the forecast period.
France Anesthesia Devices Market Trends
Anesthesia Workstation is Expected to Witness Significant Growth Over the Forecast Period
The Anesthesia Workstations consist of a ventilator, carrier gas and agent delivery system, a scavenging system, and monitors. The ability of these devices to optimize anesthesia workflow and reduce process costs with integrated features is boosting anesthesia workstation's popularity among medical professionals. The integration of various functionalities, such as oxygen saturation level, carbon dioxide level, heart rate, and blood pressure, coupled with decision support systems and data analysis to aid clinicians to get better insights on their patients, is favoring the market growth.Furthermore, the country has the presence of advanced products that are expected to accelerate market growth. For instance, in December 2021, MDoloris Medical Systems and Mindray, a global leader in developing and providing advanced medical devices and solutions, announced the CE Mark and upcoming launch of the Mdoloris ANI-MR module. Also, in October 2020, Mindray hosted a virtual launch event to introduce it's brand new A9 and A8 anesthesia systems, which are now available in Europe and other selected regions. The machines integrate automatic controlled anesthesia (ACA) and high flow nasal cannula oxygen (HFNC), which extend safe apnoeic time from 8 to up to 30 minutes to help clinicians intubate more easily. Hence all these factors are expected to propel the market growth in this segment.
France Anesthesia Devices Industry Overview
The anesthesia devices market is fragmented and the key players in the France Anesthesia Devices market are B. Braun Melsungen AG, Draegerwerk AG, Heyer Medical AG, Kalstein France, Fisher & Paykel Healthcare, GE Healthcare, Koninklijke Philips NV, and Getinge AB.Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1 INTRODUCTION
4 MARKET DYNAMICS
5 MARKET SEGMENTATION
6 COMPETITIVE LANDSCAPE
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- B. Braun Melsungen AG
- Draegerwerk AG
- Heyer Medical AG
- Kalstein France
- Fisher & Paykel Healthcare
- GE Healthcare
- Koninklijke Philips NV
- Getinge AB
Methodology
LOADING...
